These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16940181)

  • 1. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
    Hossain A; Kuo MT; Saunders GF
    Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
    Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
    Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
    Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
    Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
    Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
    Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
    Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
    Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
    Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
    Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.
    Lahusen T; Henke RT; Kagan BL; Wellstein A; Riegel AT
    Breast Cancer Res Treat; 2009 Jul; 116(2):225-37. PubMed ID: 19418218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
    Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
    Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
    Yan J; Tsai SY; Tsai MJ
    Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staying the distance: avoiding the proteasomal trap.
    Downes M; Evans RM
    Cancer Cell; 2008 Mar; 13(3):184-5. PubMed ID: 18328421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
    Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
    Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.
    Anzick SL; Azorsa DO; Simons SS; Meltzer PS
    BMC Cancer; 2003 Sep; 3():22. PubMed ID: 12964942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation.
    You D; Zhao H; Wang Y; Jiao Y; Lu M; Yan S
    Mol Cells; 2016 Sep; 39(9):663-8. PubMed ID: 27665502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.